Skip to main content
NEUP logo

NEUP · Neuphoria Therapeutics Inc. · Short Volume

Track NEUP — free
$3.51 +0.12 (+3.54%)
Market Cap
$18.34M
Shares
5.41M
Volume · Oct 21 5449 Avg daily vol (3M) 159.22K

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-10-20 54 0 11,561 0.5%
2026-10-19 717 0 25,017 2.9%
2026-10-16 14,289 0 51,543 27.7%
2026-10-15 609 0 10,349 5.9%
2026-10-14 10,165 0 27,887 36.5%
2026-10-13 4,797 0 15,514 30.9%
2026-10-12 1,337 0 3,212 41.6%
2026-10-09 321 0 1,707 18.8%
2026-10-08 516 0 12,305 4.2%
2026-10-07 24 0 936 2.6%
2026-10-06 1,972 0 11,354 17.4%
2026-10-05 2,658 0 7,097 37.5%
2026-10-02 948 0 4,806 19.7%
2026-10-01 152 0 2,779 5.5%
2026-09-30 1,412 0 2,302 61.3%
2026-09-29 3,276 0 5,020 65.3%
2026-09-28 253 0 883 28.7%
2026-09-25 326 0 758 43.0%
2026-09-24 269 0 2,447 11.0%
2026-09-23 1,378 0 7,881 17.5%
2026-09-22 631 0 1,611 39.2%
2026-09-21 1,624 0 5,730 28.3%
2026-09-18 1,113 0 2,641 42.1%
2026-09-17 114 0 1,906 6.0%
2026-09-16 2,660 0 20,910 12.7%
2026-09-15 2,919 0 4,670 62.5%
2026-09-14 3,647 0 6,658 54.8%
2026-09-11 651 0 15,342 4.2%
2026-09-10 8,121 1,300 27,955 29.1%
2026-09-09 5,380 0 13,635 39.5%
2026-09-08 4,054 0 15,293 26.5%
2026-09-04 403 0 2,890 13.9%
2026-09-03 1,872 0 4,352 43.0%
2026-09-02 2,639 0 10,900 24.2%
2026-09-01 1,979 0 8,664 22.8%
2026-08-31 2,364 0 33,122 7.1%
2026-08-28 926 0 19,337 4.8%
2026-08-27 7,935 0 26,153 30.3%
2026-08-26 260 0 30,326 0.9%
2026-08-25 6,170 2,567 25,170 24.5%
2026-08-24 1,096 0 42,381 2.6%
2026-08-21 55,976 0 71,335 78.5%
2026-08-20 8,801 0 25,084 35.1%
2026-08-19 727 0 11,953 6.1%
2026-08-18 13,146 0 35,947 36.6%
2026-08-17 5,609 0 14,333 39.1%
2026-08-14 1,023 0 4,745 21.6%
2026-08-13 1,220 0 6,146 19.9%
2026-08-12 1,146 0 5,820 19.7%
2026-08-11 537 0 21,103 2.5%
Showing 1–50 of 65 days
Key facts CIK 1191070 CUSIP 64136E102 Visit website Investor relations